Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Mar 3;3(3):643–651. doi: 10.1002/cam4.218

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Recurrence-free survival rates of patients stratified based on the treatment response of tumor markers after hepatectomy. A: Tumor marker was normal before and after hepatectomy. B: Tumor marker was elevated before hepatectomy but normalized after hepatectomy. C: Tumor marker was elevated before and after hepatectomy. D: Tumor marker was normal before hepatectomy but elevated after hepatectomy. (A) Survival rates based on the treatment response of AFP. The survival rate of patients in group C was significantly lower than that of patients in group A (P = 0.0016) and in group B (P = 0.0345). (B) Survival rates based on the treatment response of DCP. The survival rate of patients in group C was significantly lower than that of patients in group A (P < 0.0001) and in group B (P = 0.0003). (C) Survival rates based on the treatment response of conventional AFP-L3. The survival rate of patients in group C was significantly lower than that of patients in groups A and B (both, P < 0.0001). (D) Survival rates based on the treatment response of highly sensitive AFP-L3. The survival rate of patients in group C was significantly lower than that of patients in group A (P = 0.0005) and patients in group B (P = 0.0065). The survival rate of patients in group D was significantly lower than that of patients in group A (P = 0.0024) and patients in group B (P = 0.0345).